Maravai Lifesciences Holdings, Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 53.30%71.96%82.41%80.87%48.52%41.79%
EBT Margin -4.09%28.76%66.41%62.45%213.79%-100.89%
EBIT Margin 16.76%42.20%69.40%65.03%-10.95%-90.91%
EBITDA Margin 16.76%42.20%69.40%65.03%-10.95%-90.91%
Operating Margin 16.76%42.20%69.40%65.03%-10.95%-90.91%
Net Margin -3.63%27.74%58.71%55.57%-47.89%-100.17%
FCF Margin 4.87%44.63%44.26%58.76%21.00%-8.56%
Efficiency
Inventory Average 0.04B0.05B0.05B0.05B
Assets Average 1.59B2.10B1.88B1.25B
Equity Average 393.63B0.35B0.73B0.85B0.68B
Invested Capital 787.10B0.69B1.08B1.43B1.31B0.87B
Asset Utilization Ratio 0.500.420.150.21
Leverage & Solvency
Interest Coverage Ratio 0.803.9018.3328.13-0.69-4.94
Debt to Equity 3.451.370.580.660.51
Debt Ratio 0.420.390.230.350.29
Equity Ratio 0.120.280.400.530.57
Times Interest Earned 0.803.9018.3328.13-0.69-4.94
Dividends & Payouts
FCF Payout Ratio 0.950.430.290.16-0.02
Valuation
Enterprise Value 7.30B10.29B3.43B1.74B1.30B
Market Capitalization 7.23B10.06B3.70B1.94B1.38B
Return Ratios
Return on Sales -0.04%0.28%0.59%0.56%-0.48%-1.00%
Return on Capital Employed 0.37%0.29%-0.02%-0.20%
Return on Invested Capital 0.00%0.56%0.41%-0.21%
Return on Assets 0.29%0.23%-0.07%-0.21%
Return on Equity 0.00%1.34%0.68%-0.16%-0.38%